Health Care News and Research

RSS

Joint Commission's Accreditation for Shared Imaging

Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received The Joint Commission's Accreditation for Ambulatory Health Care, a nationally-recognized, prestigious gold seal of approval for quality and safety in patient care.

4 Dec 2009

Amber Pharmacy receives ACHC accreditation

Amber Pharmacy announced today that it received accreditation by the Accreditation Commission for Health Care, Inc. (ACHC) for specialized pharmacy services.

4 Dec 2009

ACAMP hosts health and medical seminar

Today ACAMP hosted a health & medical seminar, explaining how technologies like nanotechnology, biomaterials and microfluidics can play a powerful role in the creation of innovative healthcare products that help promote health and improve the quality, cost and outcomes of patient care, while opening new markets for Alberta companies worldwide.

4 Dec 2009

Senators offer cost-constainment amendment; Senate continues to discuss abortion, public option

The Associated Press: "Sens. Joe Lieberman, I-Conn., and Susan Collins, R-Maine, along with Sen. Arlen Specter, D-Pa., unveiled a package of amendments Friday that would reward Medicare patients for picking efficient doctors, require insurance companies to make public more information about claims denials and speed up programs shifting from paying providers for services to paying them for performance

4 Dec 2009

PLUS Diagnostics expands its specialty anatomic pathology services

PLUS Diagnostics announced today that it has expanded its specialty anatomic pathology services with the launch of a national hematology/oncology offering. The new service completes the company's expansion from a regional laboratory to a leading national anatomic pathology company offering diagnostic services across a full range of specialties including gastroenterology, urology and now hematology/oncology.

4 Dec 2009

Senate rejects amendment to strip proposed Medicare cuts from Senate health bill

The Washington Post: "Senate Republicans lost their first major challenge to a Democratic plan to overhaul the health-care system, as the chamber voted Thursday to reject a GOP proposal to strip the package of nearly $500 billion in Medicare cuts, its most important source of financing."

4 Dec 2009

Two examples of health innovations: A new pediatric specialty and a well-wired clinic

Newspapers report on doctors' efforts to develop new expertise to treat children who have been abused and neglected, as well as those to address a poor community's health needs with electronic health records.

4 Dec 2009

Senate bill moves forward, amendment ensures coverage for women's preventive care

Los Angeles Times: "After days of delay, Senate Democrats pushed ahead Thursday with their drive to pass a healthcare bill by Christmas, approving the first amendment to their giant bill: a measure to expand women's access to preventive services such as mammograms."

4 Dec 2009

Senate debate expected to turn to abortion

The issue that sharply divided the House during its consideration of health-care legislation is threatening to derail the Senate version of the bill, Bloomberg reports. Sen. Ben Nelson, D-Neb., has said he will help filibuster the bill unless Democrats adopt tougher language restricting federal funds from paying for abortions, and may offer an amendment to that effect.

4 Dec 2009

Democrats stress 'doughnut hole' provisions to woo senior support for reform

The Associated Press: "Lawmakers have wooed seniors skeptical of the health care overhaul by emphasizing the plan would close the 'doughnut hole' — a gap in Medicare drug coverage that can cost thousands of dollars a year. But getting support for the entire overhaul from this powerful voting bloc has been difficult, despite Democrats repeated town hall meetings, interviews and congressional hearings."

4 Dec 2009

Today's opinions and editorials

In short, if the changes that are proposed for employer subsidies in the current Medicare Part D program are enacted, everyone will lose (Tom Scully, 12/3).

4 Dec 2009

BUSM researchers report an inverse association between dairy intake and fibroid risk

Boston University School of Medicine (BUSM) researchers at the Slone Epidemiology Center found that black women with high intake of dairy products have a reduced incidence of uterine leiomyomata (fibroids). This report, based on the Black Women's Health Study, appears in the current issue of the American Journal of Epidemiology.

4 Dec 2009

Public Campaign Action Fund names Sen. Richard Burr as its final 'Insurance Puppet'

Public Campaign Action Fund, a national campaign finance watchdog group, named Sen. Richard Burr (R-N.C.) its final "Insurance Puppet" in an online advertising campaign targeting North Carolina and Washington, D.C.

4 Dec 2009

Some Doctors' groups breaking with AMA to oppose health bill

Doctors are divided over health care reform with an increasing number of them expressing opposition.

4 Dec 2009

Senate's efforts on health care being slowed by other issues

The Wall Street Journal: "The Senate's slow-moving health bill is colliding with other legislative priorities on the economy, raising chances that Democrats won't meet their goal of pushing a health-care overhaul through the chamber this month." Though some forward progress was evidenced on Thursday when the chamber, for the first time since floor consideration of the health bill began, voted on amendments.

4 Dec 2009

Fact checking lawmakers' claims about health bills

NPR began a series called "Is That So?": "As the debate about the health overhaul bill goes on (and on and on) you might find that sometimes what one Senator says seems to be the exact opposite of the next." In the first installment, NPR's Julie Rovner examined Sen. Christopher Dodd's statement: "On the day this bill is enacted, health insurance becomes a buyer's market, not a seller's market. And that's as American as apple pie," and found that "it may be so eventually, but definitely not on the day the bill is enacted."

4 Dec 2009

Allos Therapeutics, Idis collaborate in named patient program for FOLOTYN

Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

4 Dec 2009